First-in-human study of ABBV-400, a novel c-Met-targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer

被引：0

作者：

Sharma, Manish

Strickler, John H.

Sommerhalder, David

Kuboki, Yasutoshi

Perets, Ruth

Cohen, Jonathan

Raimbourg, Judith

Nakajima, Takako Eguchi

Yamamoto, Noboru

Cruz-Correa, Marcia

O'Neil, Bert

Ghiringhelli, Francois

Raghav, Kanwal Pratap Singh

Li, Rui

Thiele, Gladys Morrison

Aristide, Martha Raluca Neagu

Freise, Kevin Jay

de Almeida, Carla Biesdorf

Vasilopoulos, Athanasios

Powderly, John D., II

机构：

[1] START Midwest, Grand Rapids, MI USA

[2] Duke Univ, Sch Med, Durham, NC USA

[3] NEXT Oncol, San Antonio, TX USA

[4] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[5] Rambam Med Ctr, Haifa, Israel

[6] Technion Israel Inst Technol, Haifa, Israel

[7] Hebrew Univ Jerusalem, Sharett Inst Oncol, Wohl Inst Translat Med, Hadassah Med Ctr,Hadassh Hebrew Univ Med Ctr, Jerusalem, Israel

[8] Ctr Rene Gauducheau, Insit Cancerol Ouest, St Herblain, France

[9] Kyoto Univ, Grad Sch Med, Kyoto, Japan

[10] Natl Canc Ctr, Tokyo, Japan

[11] Univ Puerto Rico, Med Sci Campus, San Juan, PR USA

[12] Pan Amer Ctr Oncol Trials, San Juan, PR USA

[13] Community Hlth Canc Ctr North, Indianapolis, IN USA

[14] Ctr Georges Francois Leclerc, Dijon, France

[15] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[16] AbbVie Inc, N Chicago, IL USA

[17] Carolina Biooncol Inst, Huntersville, NC USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3515

引用

页数：1